MOLECULAR TESTING FOR HPV

Oncogenic human papilloma virus (HPV) positive head and neck squamous cell carcinoma is potentially curable. Treatment planning requires these cancers to be accurately identified.  Austpath tests these cancers with a combination of p16 immunohistochemistry and molecular testing for HPV DNA in situ by hybridization. 

REFERENCES : 

HPV Specific Testing: A Requirement for Oropharyngeal Squamous Cell Carcinoma Patients.

Robinson M, Schache A, Sloan P, Thavaraj S. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol. 2012 Jul;6 Suppl 1:S83-90. doi: 10.1007/s12105-012-0370-7. Epub 2012 Jul

Human papillomavirus and oropharynx cancer: biology, detection and clinical implications.

Allen CT, Lewis JS Jr, El-Mofty SK, Haughey BH, Nussenbaum B. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope. 2010 Sep;120(9):1756-72. doi: 10.1002/lary.20936.

LEGAL

AUSTPATH LABORATORIES

197 Briens Road

Northmead NSW 2152

Telephone : 02 8836 3333